A

California legislator is taking another stab at gaining transparency into drug pricing by introducing a bill that would require drug makers to notify state officials about planned price increases and to also justify price hikes. At the same time, the legislation would also require health plans to provide detailed information about drug costs and the portion of premiums attributed to this expense.

“Millions of Californians have health insurance, but affordability remains a critical issue,” state Senator Edward Hernandez in a statement to announce the bill. “The favorite tactic of drug companies is to help consumers with their co-payments, but all this does is shield consumers from the true cost of the drug while driving up insurance premiums for everyone.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.